Market Analysis - Parasitology 2017
Performs basic research here parasite of humans and animals at the level of molecules, cells and whole organisms. The mission is to acquire, enhance and distribute knowledge about the biology and ecology of parasitic protozoa and eukaryotic microorganisms, helminths and arthropods. The Institutes in Czech Republic carries out not only research but also education on a national and international level. The main research areas encompass parasitology, helminthology, and medical entomology, including studies on the causative agents of the infections transmitted by arthropods.
- General Parasitology
- Medical Protozoology
- Medical Helminthology
- Medical Parasitology
- Medical Entomology
- Veterinary Parasitology
- Fish Parasites & risks to Public Health
- Experimental Immunoparasitology
- Structural Parasitology
- Molecular and Biochemical Parasitology
- Tropical Parasitology
- Vector-borne Diseases
- Ticks and Tick-borne Diseases
- The Health Policy Environment
- Approaches to Control Parasitic Diseases
Parasitic infections affect millions of people every year:
- More than 300,000 persons living are infected with Trypanosoma cruzi, the cause of Chagas disease.
- At least 1,000 people are hospitalized with neurocysticercosis every year.
- Each year at least 70 people, most of them children, are blinded by the parasite that causes Toxocariasis.
- More than 60 million persons are chronically infected with Toxoplasma gondii.
- Each year 1.1 million people are newly infected with Trichomonas.
WHO estimates that about 655,000 people die from malaria every year, though a recent systematic analysis suggested the true annual mortality is closer to 1.24 million (Murray et al., 2012). Inexpensive oral drugs—chloroquine and sulfadoxine-pyrimethamine—were once common treatment for malaria, but resistance to these treatments is widespread (WHO, 2012c). Since 2001, the WHO has recommended treating malaria with artemisinin combination therapies (WWARN, 2012c). The use of artemisinin combination drugs as first-line therapy is essential to malaria control. As of 2006, however, there is evidence of artemisinin resistance in Southeast Asia (WWARN, 2012c).
Market Value for Antimalarial Drugs
Two hundred and eighteen antimalarial drugs were in circulation in Kenya in 2002. These included 65 "sulfur"-pyrimethamine (sulfadoxine-pyrimethamine and sulfalene-pyrimethamine (SP), the first-line recommended drug in 2002) and 33 amodiaquine (AQ, the second-line recommended drug) preparations. Only half of SP and AQ products were registered with the Pharmacy and Poisons Board. Of SP and AQ brands at district level, 40% and 44% were officially within legal registration requirements. 29% of retailers at district level stocked SP and 95% stocked AQ. The retail price of adult doses of SP and AQ were on average 0.38 and 0.76 US dollars, 100% and 347% higher than trade prices from manufacturers and importers. Artemether-lumefantrine, the newly announced first-line recommended antimalarial drug in 2004, was found in less than 1% of all retail outlets at a median cost of 7.6 US dollars.
Market Growth of Parasitic Drugs Manufacturers Worldwide
Market Growth of Parasitic Drugs Manufacturers Worldwide
Fund Allotment to Parasitology Research
Conferencesseries invites all the participants from all over the world to attend '4th International Conference on Parasitology' during September 01-02, 2017 in Prague, Czech Republic which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Parasitology-2017 is to gathering people in academia and society interested in parasitology to share the latest trends and important issues relevant to our field/subject area. The scientific programme of the conference is broad and embraces different research aspects with focus on applied and ecological parasitology, and in particular with a veterinary and medical interest. The conference will include invited speakers, oral presentations, poster session and the young scientist award. Conferenceseries organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Why to attend??
With members from around the world focused on learning about parasitology and its advances; this is your best opportunity to reach the largest assemblage of participants from the parasitology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Parasitology are hallmarks of this conference.
- Parasitology Students, Scientists
- Parasitology Researchers
- Parasitology Faculty
- Medical Colleges
- Parasitology Associations and Societies
- Business Entrepreneurs
- Training Institutes
- Manufacturing Medical Devices Companies
Conferenceseries LLC invites all the participants from all over the world to attend '4th International Conference on Parasitology' during September 01-02, 2017 in Prague, Czech Republic which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Parasitology-2017 is to gathering people in academia and society interested in parasitology to share the latest trends and important issues relevant to our field/subject area. The scientific program of the conference is broad and embraces different research aspects with focus on applied and ecological Parasitology, and in particular with a veterinary and medical interest. The conference will include invited speakers, oral presentations, poster session and the young scientist award.